Breast cancer screening: time to target women at risk.
作者信息
Hall P, Easton D
出版信息
Br J Cancer. 2013 Jun 11;108(11):2202-4. doi: 10.1038/bjc.2013.257. Epub 2013 Jun 6.
Abstract
摘要
相似文献
1
Breast cancer screening: time to target women at risk.乳腺癌筛查：是时候针对高危女性了。
Br J Cancer. 2013 Jun 11;108(11):2202-4. doi: 10.1038/bjc.2013.257. Epub 2013 Jun 6.
2
'A low risk is still a risk': exploring women's attitudes towards genetic testing for breast cancer susceptibility in order to target disease prevention.“低风险仍是风险”：探索女性对乳腺癌易感性基因检测的态度以实现疾病预防目标
Public Health Genomics. 2011;14(4-5):238-47. doi: 10.1159/000276543. Epub 2010 Jan 14.
3
Screening women at increased risk with MRI.对高危女性进行磁共振成像筛查。
Cancer Imaging. 2005 Nov 23;5 Spec No A(Spec No A):S10-5. doi: 10.1102/1470-7330.2005.0040.
4
Does screening for breast cancer with five screening modalities in average-risk women reduce mortality from breast cancer?
J Am Coll Surg. 2013 Jun;216(6):1214-7. doi: 10.1016/j.jamcollsurg.2013.03.010.
5
The impact of breast cancer screening among younger women in the Barretos Region, Brazil.巴西巴雷托斯地区年轻女性乳腺癌筛查的影响。
Anticancer Res. 2013 Jun;33(6):2651-5.
6
The ANDROMEDA prospective cohort study: predictive value of combined criteria to tailor breast cancer screening and new opportunities from circulating markers: study protocol.ANDROMEDA 前瞻性队列研究：联合标准预测乳腺癌筛查的价值及循环标志物带来的新机遇：研究方案。
BMC Cancer. 2017 Nov 22;17(1):785. doi: 10.1186/s12885-017-3784-5.
7
[Breast cancer].
Gan To Kagaku Ryoho. 2012 Jan;39(1):27-32.
8
The limitations of breast cancer screening for first-degree relatives of breast cancer patients.乳腺癌患者一级亲属的乳腺癌筛查局限性。
Am J Public Health. 1995 Jun;85(6):832-4. doi: 10.2105/ajph.85.6.832.
9
Effects of education based on the health belief model on screening behavior in high risk women for breast cancer, Tehran, Iran.基于健康信念模式的教育对伊朗德黑兰乳腺癌高危女性筛查行为的影响
Asian Pac J Cancer Prev. 2011;12(1):49-54.
10
[Breast cancer screening for women with a strong familial risk].[对具有高家族风险的女性进行乳腺癌筛查]
Bull Cancer. 2005 Oct;92(10):874-84.
引用本文的文献
1
Implementing the Risk Stratification and Clinical Management of Breast Cancer Families Using Polygenic Risk Score Evaluation: A Pilot Study.使用多基因风险评分评估实施乳腺癌家族的风险分层和临床管理：一项试点研究。
J Pers Med. 2024 Sep 27;14(10):1034. doi: 10.3390/jpm14101034.
2
Clinical Impact of Polygenic Risk Score for Breast Cancer Risk Prediction in 382 Individuals with Hereditary Breast and Ovarian Cancer Syndrome.多基因风险评分对382例遗传性乳腺癌和卵巢癌综合征患者乳腺癌风险预测的临床影响
Cancers (Basel). 2023 Aug 2;15(15):3938. doi: 10.3390/cancers15153938.
3
Integration of a Cross-Ancestry Polygenic Model With Clinical Risk Factors Improves Breast Cancer Risk Stratification.基于跨血统多基因模型与临床风险因素的整合提高了乳腺癌风险分层。
JCO Precis Oncol. 2023 Feb;7:e2200447. doi: 10.1200/PO.22.00447.
4
Machine Learning Approaches with Textural Features to Calculate Breast Density on Mammography.基于纹理特征的机器学习方法计算乳腺 X 线摄影中的乳腺密度。
Curr Oncol. 2023 Jan 7;30(1):839-853. doi: 10.3390/curroncol30010064.
5
Polygenic risk scores: An overview from bench to bedside for personalised medicine.多基因风险评分：从实验室到床边的个性化医疗概述
Front Genet. 2022 Nov 11;13:1000667. doi: 10.3389/fgene.2022.1000667. eCollection 2022.
6
Use of Breast Cancer Risk Factors to Identify Risk-Adapted Starting Age of Screening in China.利用乳腺癌危险因素在中国确定风险适应的筛查起始年龄。
JAMA Netw Open. 2022 Nov 1;5(11):e2241441. doi: 10.1001/jamanetworkopen.2022.41441.
7
BREAst screening Tailored for HEr (BREATHE)-A study protocol on personalised risk-based breast cancer screening programme.基于个体风险的乳腺癌筛查项目的个体化筛查方案（BREATHE）研究方案。
PLoS One. 2022 Mar 31;17(3):e0265965. doi: 10.1371/journal.pone.0265965. eCollection 2022.
8
Risk of Breast Cancer Among Carriers of Pathogenic Variants in Breast Cancer Predisposition Genes Varies by Polygenic Risk Score.携带乳腺癌易感基因致病性变异的个体患乳腺癌的风险因多基因风险评分而异。
J Clin Oncol. 2021 Aug 10;39(23):2564-2573. doi: 10.1200/JCO.20.01992. Epub 2021 Jun 8.
9
Correlation between FAS single nucleotide polymorphisms and breast carcinoma susceptibility in Asia.亚洲人群中FAS单核苷酸多态性与乳腺癌易感性的相关性
Medicine (Baltimore). 2019 Dec;98(49):e18240. doi: 10.1097/MD.0000000000018240.
10
Association of Microcalcification Clusters with Short-term Invasive Breast Cancer Risk and Breast Cancer Risk Factors.微钙化簇与短期浸润性乳腺癌风险及乳腺癌危险因素的相关性。
Sci Rep. 2019 Oct 10;9(1):14604. doi: 10.1038/s41598-019-51186-w.
本文引用的文献
1
The benefits and harms of breast cancer screening: an independent review.乳腺癌筛查的益处与危害：一项独立综述。
Br J Cancer. 2013 Jun 11;108(11):2205-40. doi: 10.1038/bjc.2013.177. Epub 2013 Jun 6.
2
Genome-wide association studies identify four ER negative-specific breast cancer risk loci.全基因组关联研究确定了四个 ER 阴性特异性乳腺癌风险位点。
Nat Genet. 2013 Apr;45(4):392-8, 398e1-2. doi: 10.1038/ng.2561.
3
Large-scale genotyping identifies 41 new loci associated with breast cancer risk.大规模基因分型鉴定出 41 个与乳腺癌风险相关的新位点。
Nat Genet. 2013 Apr;45(4):353-61, 361e1-2. doi: 10.1038/ng.2563.
4
The benefits and harms of breast cancer screening: an independent review.乳腺癌筛查的获益与危害：一项独立评审。
Lancet. 2012 Nov 17;380(9855):1778-86. doi: 10.1016/S0140-6736(12)61611-0. Epub 2012 Oct 30.
5
Polygenic susceptibility to prostate and breast cancer: implications for personalised screening.多基因易感性与前列腺癌和乳腺癌：对个体化筛查的启示。
Br J Cancer. 2011 May 10;104(10):1656-63. doi: 10.1038/bjc.2011.118. Epub 2011 Apr 5.
Zotero 插件